Fig.1

FDFT1 exhibits low expression and is positively correlated with prognosis of GC. a Data from Kaplan–Meier Plotter to show the OS between GC patients with low-expression and high-expression FDFT1. b Data from Kaplan–Meier Plotter to show the OS between GC patients as in (a), who were stratified according to TNM stage. c Data from Kaplan–Meier Plotter to show the PFS between GC patients with low-expression and high-expression FDFT1. d Data from Kaplan–Meier Plotter to show the PFS between GC patients as in (c), who were stratified according to TNM stage. e qRT-PCR analysis to show FDFT1 mRNA expression in 50 pairs of GC and adjacent noncancerous tissues. f IHC analysis to show FDFT1 protein expression as in (e). One case is displayed. Scale bar: 100 mm. g Histogram to display the IHC scores of clinical specimens as in (e). h WB analysis to determine FDFT1 expression in MGC-803, HGC-27, SGC-7901, AGS, MKN-28, BGC-823 and GES-1. Data are presented as means ± SD. **P < 0.01; ***P < 0.001